TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Other Events

TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Other Events
Item 8.01

On December 4, 2020, Tonix Pharmaceuticals Holding Corp (the “Company”) announced independent researchers reported 99.7% colinear identity between a circa 1860 U.S. smallpox vaccine and horsepox virus. This finding indicates that a true horsepox virus was used as a smallpox vaccine in the U.S. in the 1860’s. The Company’s TNX-801 vaccine candidate is a live virus vaccine based on synthesized horsepox being developed to prevent smallpox. TNX-801 is the vector for the Company’s TNX-1800 vaccine candidate being developed to prevent COVID-19.

A copy of the press release that discusses this matter is filed as Exhibit 99.01 hereto and incorporated herein by reference.

   
99.01 Press Release dated December 4, 2020, issued by the Company


Tonix Pharmaceuticals Holding Corp. Exhibit
EX-99.01 2 ex99-01.htm PRESS RELEASE   Tonix Pharmaceuticals Holding Corp. 8-K   Exhibit 99.01   Vaccine Genome Researchers Report 99.7% Colinear Identity Between a U.S. Civil War Era Smallpox Vaccine and Horsepox Virus   Findings Published in the Current Issue of the Journal Genome Biology   Horsepox is the Vector for Tonix’s Experimental TNX-1800 COVID-19 Vaccine   Horsepox Has Been Used as a Smallpox Vaccine Since at Least the 1860’s   Smallpox is the Only Viral Disease Ever Eradicated     CHATHAM,…
To view the full exhibit click here

An ad to help with our costs